Found 44 results

2010
Turnbull F, Woodward M, Anna V.  2010.  Effectiveness of blood pressure lowering: evidence-based comparisons between men and women. Expert Review of Cardiovascular Therapy. 8:199-209.[IF0.000].
PROGRESS Collaborative Group, Writing Committee, Arima H, Tzourio C, Anderson C, Woodward M, Bousser MB, Macmahon S, Neal B, Chalmers J.  2010.  Effects of perindopril-based blood pressure lowering on probable cerebral amyloid angiopathy-related intracerebral hemorrhage: the PROGRESS trial. Stroke. 41 :394-6.[IF6.499].
Czernichow S , Lee CMY, Barzi F , Greenfield J, Baur LA, Chalmers J, Woodward M, Huxley RR.  2010.  Efficacy of weight-loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomised controlled trials. . Obesity Reviews . 11:150-8.[IF7.821].
ADVANCE Collaborative Group, Writing Committee, Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S et al..  2010.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia. Epub. [IF 6.418]
PROGRESS Collaborative Group, Writing Committee, Arima H, Anderson C, Omae T, Liu L, Tzourio C, Woodward M, Macmahon S, Neal B et al..  2010.  Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. Journal of Hypertension. 28 :395-400.[IF5.132].
2009
Woodward M, Croft KD, Mori TA, Headlam H, Wang XS, Suarna C, Raftery MJ, MacMahon SW, Stocker R.  2009.  Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. Clin Sci. 116:53-60.[IF0].
Batty D, Barzi F , Woodward M, Jamrozik K, Wong JW, Kim HC, Ueshima H, Huxley RR.  2009.  Adult height and cancer mortality: The Asia Pacific Cohort Studies Collaboration. Annals Oncology. Epub. [IF 4.935].
Asia Pacific Cohort Studies Collaboration, Lee CM, Barzi F , Woodward M, Batty GD, Giles G, Wong JW, Jamrozik K, Lam TH, Ueshima H et al..  2009.  Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region . 21,000 deaths in 510,000 participants . Int J Epidemiol. 38:1060-71.[IF5.151].
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
Tunstall-Pedoe H, Woodward M, Watt G.  2009.  ASSIGN, QRISK and Validation. British Medical Journal. 339:b3514.[IF12.827].
Welsh P, Woodward M, Rumley A, Lowe G.  2009.  Associations of circulating TNF and IL-18 with myocardial infarction and cardiovascular risk markers: The Glasgow Myocardial Infarction Study. Cytokine. 47:143-7.[IF2.214]..
Asia Pacific Cohort Studies Collaboration, Writing Committee, O’Seaghdha CM, Perkovic V, Lam TH, McGinn S, Barzi F , Gu DF, Cass A, Suh I et al..  2009.  Blood pressure is a major risk factor for renal death. An analysis of 560 352 participants from the Asia-Pacific region. . Hypertension . 54:509-15.[IF7.368]..
ADVANCE Collaborative Group, Writing Committee, Kengne A-P , Czernichow S , Huxley R , Grobbee D, Woodward M, Neal B, Zoungas S, Cooper M et al..  2009.  Blood pressure variables and cardiovascular risk: New findings from ADVANCE.. Hypertension. 54:399-404.[IF7.368]..
Turnbull FM, Woodward M.  2009.  Calcium antagonists revisited. Journal of Hypertension. 27:1121-2.[IF5.132].
Huxley R , Lee C, Barzi F , Timmermeister L, Czernichow S , Perkovic V, Grobbee D, Batty D, Woodward M.  2009.  Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type-II Diabetes Mellitus: A Systematic Review with Meta-analysis. Archives of Internal Medicine. 169:2053-63.[IF9.110].
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
ADVANCE Collaborative Group, Writing Committee, Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, Macmahon S, Marre M et al..  2009.  The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care. 32:2068-74.[IF7.349].
Baber U, Mann D, Shimbo D, Woodward M, Olin JW, Muntner P.  2009.  Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. American Journal of Cardiology. 104:1446-51.[IF3.905].
Obesity in Asia Collaboration, (Writing Committee), Barzi F , Woodward M, Czernichow S , Ying Lee CM, Kang JH, Janus E, Lear S, Patel A et al..  2009.  The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia Pacific Region: The Obesity in Asia Collaboration. Obesity Reviews . Epub. [IF 5.569].
Woodward M, Welsh P, Rumley A, Tunstall-Pedoe H, Lowe GDO.  2009.  Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a ten-year cohort study in Glasgow, Scotland European Heart Journal. Epub. [IF 8.917].
Asia Pacific Cohort Study Collaboration, Nakamura K, Barzi F , Huxley R , Lam TH, Suh I, Woo J, Kim HC, Feigin V, Gu D et al..  2009.  Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart. Epub. [IF 4.141].
Woodward M, Tunstall-Pedoe H, Rumley A, Lowe G.  2009.  Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study British Journal of Haematology. 146:442-6[IF4.487]..
Travakoli M, Pumford N, Woodward M, Doney A, Chalmers J, Macmahon S, MacWalter R.  2009.  An economic evaluation of a Perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. Eur J Health Econ . 10:111-9.[IF0.000]..
PROGRESS Collaborative Group, [Writing Committee], Ninomiya T, Donnan G, Anderson N, Bladin C, Chambers B, Gordon G, Sharpe N, Chalmers J et al..  2009.  Effects of the end point adjudication process on the results of the perindopril protection against recurrent stroke study (PROGRESS). Stroke . 40 :2111-5.[IF6.2]..
Anna V, Woodward M.  2009.  Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association. Womens Health (Lond Engl) . 5:625-8.[IF0.000].

Latest news

Recently added pages

Our focus

George Institute sites